Tuesday, October 20, 2026

From Fat to Follicles - Is Hair Loss the Next Blockbuster?

Novo Nordisk has only floated hair loss, while Veradermics’ Phase 3 oral minoxidil data lead a field of licensing and takeover candidates.

MANE $4.8B

Cestrian Capital Research 21h ago 33 clicks

30h ago MYRG $4.4B

Monte Investments Market Brief Vol. CXXXII

Monte Independent Investment Research 8 clicks

32h ago GPI $2.9B

Group 1 Automotive: The Debt Stress Test

Cannibal Stocks 12 clicks

From X

@BarbarianCap Oct 14 1 click

Barbarian Capital on X

@GodelTerminal $PM market share 85% $TPB market share 15% Source: me looking at the box

@StableBread Oct 14

Fajasy on X

The CEO of Nubeva Technologies $NBVAF (TSXV: $NBVA) expects its third AI patent to be approved within two months, calling the rest “signature paperwork.” Nubeva, a ransomware recovery company, has been granted two of the four AI patents it applied for in 2024. CEO Randy Chou said in his October 5, 2026 interview on Nubeva’s YouTube channel that the patent office had sent an amendment on the third patent that week, which Nubeva plans to accept. The third patent covers detecting “nefarious or improper encryption” inside a binary (a compiled program in machine code), meaning Nubeva can tell when malware is encrypting files, even when the encryption is hidden. Spotting hidden encryption is also what drew AI data labeling companies (firms that turn experts’ knowledge into training data for AI labs) to Nubeva, Chou said. Nubeva hasn’t heard back on the fourth patent. Chou said the patent office told the company that AI patent applications are now taking much longer, with examiners reading filings as long as 150 pages vs. the ~30 pages he typically files (probably because of AI writing the patents). So the fourth patent, the last one Chou wants granted before pursuing a potential partnership or sale, is just a waiting game.

@ACapitalLP Oct 14 1 click

A Capital on X

Wow - $GLND is uniquely positioned to capitalize on this! https://t.co/xjVZnf563K

@TimyanBankAlert Oct 14

Timyan Bank Alert on X

@charrisinvest He doesn’t. Buying those unexercised rights shares of $BAFN was free $. The man struck a great deal for himself here. All set up by the idiocy in the c suite and board.

@valuedontlie Oct 14 1 click

Colin King on X

Not good for $FUN https://t.co/x8mOtJPthw

@ACapitalLP Oct 14

A Capital on X

@grok @grok are these good or bad convert terms for $CIFR?

@Adam_Wyden Oct 14 3 clicks

Adam D. Wyden on X

I had an LP call my “shitco” … “snackwell”…. They can “snack” on this. $STGW @Mark_Penn @jayleveton @ballan11 Funny thing is it’s still 6x PE in 2027 ahead of a generational 2028 political year. $makeshitcosgreatagain $compoundersat30xPEnotthesamewith10yrat5pct $makingmoneythehardway. Or easy way?

@ACapitalLP Oct 14 1 click

A Capital on X

Rothschild out with a great piece on $KYIV. Such a strong fundamental business hampered by an enormous war discount. Any credible peace deal would not only remove the geopolitical overhang but also accelerate the underlying business through lower costs, reduced capex and significantly higher FCF. A double catalyst: multiple expansion (war discount removal) and fundamental acceleration…

Carecloud News

CareCloud may attract a private-equity buyer after its Q3 call, with acquiring enough shares the main obstacle to a take-private deal.

CCLD $79M

Calvin Blissett 19h ago 7 clicks

💥Hain Celestial: Earthly Issues💥

Hain Celestial sold its North American snacks business for $115 million as declining sales and EBITDA left $558 million of secured debt…

HAIN $26M

PETITION 29h ago 5 clicks

LCNB: Solid Q3 2026 With A 4.7% Yield

LCNB’s Q3 2026 net interest income rose 8.6% year over year as the bank beat revenue and EPS estimates, while trading at a 27% discount to…

LCNB $268M

Sorrento Research 34h ago 2 clicks

LXS.DE: a 2028 sale it can force

Lanxess can force Advent to buy at least half its Envalior stake in April 2028, potentially raising about €745 million to reduce net debt.

LPTH $525M

Trade Ideas Flow Oct 19 21 clicks

Sell Eagle Point Credit Now - Match The Loss With Portfolio Gains To Lower Income Taxes

Eagle Point Credit's NAV is down 25% YTD and shares nearly 50%, while its expense ratio climbed to 9.21% despite a 25% yield.

ECC $379M

Anthony Cataldo Oct 19 5 clicks

Build-A-Bear: A Narrower Path

Build-A-Bear's push into prestuffed toys and broader retail distribution tests brand stretchability, but recent results warrant caution.

BBW $303M

TSOH Investment Research Oct 19 17 clicks

The Monday Morning Briefing: Meta, Tesla, Netflix, P&G on Deck

Lennar’s land-bank costs pressure homebuilding margins, while Flowers Foods weighs a Tastykake sale after falling branded-bread share,…

FLO $1.3B

Latticework by MOI Global Oct 19 34 clicks

LendingTree (NASDAQ: $TREE) – A Cyclical Comeback Story Priced as if the Cycle Never Turns

LendingTree derives roughly two-thirds of revenue from insurance and trades near 4 times expected adjusted earnings despite record revenue,…

TREE $362M

Substack von Philipp Oct 19 10 clicks

Our Q3 2026 Update: Our Companies (OXY, RIG, VAL)

Occidental Petroleum’s debt should fall further after Q3 oil prices averaged $85 per barrel WTI and $91 Brent.

RIG $6.5BVAL $5.8B

Open Insights Oct 19 14 clicks

40 Stock Pitches (12th-18th October) 🖨️

Elutia’s antibiotic-eluting surgical matrices target breast-surgery infections, with Minot Light valuing $100 million in sales at a…

ELUT $36M

Capital Employed Oct 19 67 clicks

CHGG · long

Chegg Inc

Chegg is framed as a binary long with 500% upside against 20% downside.

CHGG $78M

Value Investors Club Jul 22 14 clicks

Undercovered Dozen: Hess Midstream, Iovance Biotherapeutics, Netlist, And More

Hess Midstream, Iovance Biotherapeutics, Netlist and nine other lesser-covered stocks make this week’s Undercovered Dozen.

HESM $6.3BIOVA $6.7B

The Undercovered Dozen Oct 18 15 clicks

SiriusXM: Dirt Cheap, Looming Catalysts, Short Squeeze Candidate

SiriusXM trades at 6.5 times free cash flow, a 15% yield, with high short interest and catalysts that could drive a short squeeze.

SIRI $9B

Eagle Point Capital Oct 17 59 clicks

Meritage Homes: Cheaper On Book Than Any Year-End In A Decade

MTH $3.8B

Tim Travis Oct 17 10 clicks

GLOO: Gloo's own filings make the short case

Gloo's $3.25 follow-on, going-concern warning and $28.0 million first-half cash burn frame the short case against its acquisition-driven…

GLOO $298M

Guardian Research Oct 16 17 clicks

Twenty Years in the Dark

Tower Properties, $TPRP, went dark after a 2006 squeeze-out cut holders below 300, leaving a Kemper-controlled apartment and office…

TPRP $128M

Orphan REITs Oct 16 5 clicks

TSOH Weekly Roundup (10/16/2026)

Bumble agreed to a $1.3 billion take-private deal, while Netflix cut about 1,000 jobs and Meta discussed its Muse superintelligence models.

BMBL $783M

TSOH Investment Research Oct 16 12 clicks

Dorchester Minerals: Variable Royalty Income Without Enough Valuation Discount

Dorchester Minerals' 9.5% normalized yield and debt-free royalty model are offset by limited upside at $29.71, as extraordinary…

DMLP $1.5B

Atlas Diary Oct 16 3 clicks

Tuya: A Global Smart-Home Platform Priced Like a Cash Box

Tuya’s $976 million cash pile equals 94% of its $1.04 billion market cap as its smart-home platform returned to 16% revenue growth in Q2…

TUYA $1.1B

Substack von Philipp Oct 16 43 clicks

PesoRama: Research Flash

PesoRama will reach 54 JOi Dollar Plus stores by November after raising C$28.4 million, funding more than 50 additional Mexican store…

TBBB $6.8B

Atrium Research - Equity Research Oct 15 7 clicks

Tuesday, October 20, 2026

Barbarian Capital on X

Fajasy on X

A Capital on X

Timyan Bank Alert on X

Colin King on X

A Capital on X

Adam D. Wyden on X

A Capital on X

Investor Letters

Publications we follow

Newsletters 108

YouTube 4

Blogs 15

Seeking Alpha 53 of 245

X accounts we follow

Investor letters we follow

Sectors